Vedolizumab as induction and maintenance therapy for ulcerative colitis.
Vedolizumab as induction and maintenance therapy for ulcerative colitis.
B. Feagan,P. Rutgeerts,13 Authors,A. Parikh
2013 · DOI: 10.1056/NEJMoa1215734
New England Journal of Medicine · 2,243 Citations
TLDR
Vedolizumab was more effective than placebo as induction and maintenance therapy for ulcerative colitis and the frequency of adverse events was similar in the vedolIZumab and placebo groups.